Cruise stocks rally after FDA approval of Pfizer COVID-19 vaccine

Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc. and partner BioNTech SE boosted hopes for increased vaccination rates. Carnival Corp.'s stock ran up 2.6%, Norwegian Cruise Line Holdings Ltd. shares climbed 3.0% and Royal Caribbean Group tacked on 1.1%. In comparison, the S&P 500 advanced 0.9%. The companies have required its staff and guests on most of their cruises to be vaccinated. Acting FDA Commissioner Janet Woodcock said the FDA approval of the Pfizer-BioNTech vaccine "may now instill additional confidence to get vaccinated." Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Cruise stocks rally after FDA approval of Pfizer COVID-19 vaccine
Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc. and partner BioNTech SE boosted hopes for increased vaccination rates. Carnival Corp.'s stock ran up 2.6%, Norwegian Cruise Line Holdings Ltd. shares climbed 3.0% and Royal Caribbean Group tacked on 1.1%. In comparison, the S&P 500 advanced 0.9%. The companies have required its staff and guests on most of their cruises to be vaccinated. Acting FDA Commissioner Janet Woodcock said the FDA approval of the Pfizer-BioNTech vaccine "may now instill additional confidence to get vaccinated." Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.